NASDAQ · OABI
OmniAb, Inc.
$5.23-$0.05 (-0.95%)
OmniAb, Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.68% below the high.
Loading market information…
NYSE · FPAC · USD
Stock price, earnings
Quote as of Mar 7, 2023, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Far Peak Acquisition Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Far Peak Acquisition Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2020 and headquartered in New York, Far Peak Acquisition Corporation currently lacks significant active operations. Its stated objective is to pursue and execute a business combination – which could take the form of a merger, acquisition of shares or assets, or a corporate reorganization – with one or more enterprises specializing in the financial technology, broader technology, or financial services sectors.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$5.23-$0.05 (-0.95%)
OmniAb, Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.68% below the high.
$9.36$0.00 (0.0%)
VPC Impact Acquisition Holdings’s quoted price sits in the lower half of its reported 52-week range, 4.39% below the high.
$10.24-$0.01 (-0.05%)
MSD Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$10.18-$0.01 (-0.1%)
Lazard Growth Acquisition Corp. I’s quoted price sits in the lower half of its reported 52-week range, 4.41% below the high.
$10.21+$0.01 (+0.1%)
Warburg Pincus Capital Corporation I-B’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$10.19-$0.02 (-0.15%)
Independence Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 5.87% below the high.
$10.03-$0.02 (-0.25%)
Ares Acquisition Corporation III’s quoted price sits in the lower half of its reported 52-week range, 6.7% below the high.
$10.49-$0.02 (-0.19%)
Fusion Acquisition Corp. II’s quoted price sits in the upper half of its reported 52-week range, 2.42% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
